9th International Science Congress (ISC-2019).  International E-publication: Publish Projects, Dissertation, Theses, Books, Souvenir, Conference Proceeding with ISBN.  International E-Bulletin: Information/News regarding: Academics and Research

A Controlled Study on Predictors of Type 2 Diabetes in Nodular Diabetic Glomerulosclerosis

Author Affiliations

  • 1 Dept. of General medicine, Princess Esra Hospital, Deccan College Of Medical Sciences, Hyderabad, AP, INDIA
  • 2 Clinical pharmacist, Dept. of General Medicine, Princess Esra Hospital, Hyderabad, INDIA

Int. Res. J. Medical Sci., Volume 2, Issue (9), Pages 9-15, September,28 (2014)

Abstract

Nodular Diabetic Glomerulosclerosis is one of the most familiar diabetic micro vascular complication. A considerable number type 2 diabetic patients are diagnosed regardless of microalbuminuria and with unconcealed and observable nephropathy upon preliminary examination. About 32 to 42% patients with microalbuminuria in type 2 diabetes develops of noticeable nephropathy with in 4 to 5 years, under standard therapy. It is a case control study. Conducted From January to July 2014.Patients visiting the in-patient department of general medicine are selected who has a history of type 2 diabetes mellitus for more than 5-10 years. The diagnosis of diabetic nephropathy was confirmed by 24 hours urine for albumin excretion rate. The study conducted with an aim to estimate the prevalence of 24 hours urinary albumin excretion and to evaluate the etiologic evidence of urinary albumin, creatinine clearance, Serum creatinine, Blood urea. The results show that The mean 24hour urine albumin level in diabetic nephropathy patients was about 539.65 406.37 and 70.334.52 of the control group. In our study it was found that the combineMean creatinine clearance of males and females in Diabetic nephropathy patients was about 20.524.20 and 94.958.67 of the control group. serum creatinine clearance also helps in providing the information about how well the kidneys are working. the study concludes thatThe role of albumin excretion is very important to detect diabetic nephropathy which is the leading cause of renal disease. And serum creatinine clearance also helps in providing information about the progression of ESRD.

References

  1. Katherine Tuttle, Md, The Evaluation Of Diabetic Nephropathy: Preventing Complications, Adv Stud Med., 5(1a), S20-S27 (2005)
  2. Viswanathan V., Snehalatha C., Kumutha R., Jayaraman M. and Ramachandran A., Serum Albumin Levels in Different Stages of Type 2 Diabetic Nephropathy Patients, Indian J Nephrol, 14, 89-92 (2004)
  3. Management of Diabetes in Chronic Renal Failure, Indian J Nephrol, 15(1), S23-S31 (2005)
  4. Alan R. Dyer, Philip Greenland Et Al, Evaluation of Measures of Urinary Albumin Excretion in Epidemiologic Studies, Am J Epidemiol, 160, 11221131 (2004)
  5. Peter Rossing, Eva Hommel Et Al, Impact of Arterial Blood Pressure and Albuminuria on the Progression of Diabetic Nephropathy in Iddm Patients, Diabetes, 42, 715-719 (1993)
  6. Mogensen C.E., Microalbuminuria as a Predictor of Clinical Diabetic Nephropathy, Kidney International, 31, 673589 (1987)
  7. Abrahamcohen-Bucay Et Al, Urinarymarkers of Glomerular Injury In Diabetic Nephropathy, Int J Nep, 1-11 (2012)
  8. Mogensen Ce. Blood Pressure Changes And Renal Function Changes In Overt Diabetic Nephropathy, Hypertension, 7(11), 64-11-73 (1985)
  9. Frank Pistrosch Et Al, Rosiglitazone Improves Glomerular Hyperfiltration, Renal Endothelial Dysfunction, And Microalbuminuria of Incipient Diabetic Nephropathy In Patients, Diabetes, 54, 2206-2211 (2005)
  10. Henrik P. Hansen Et Al, Effect of Dietary Protein Restriction on Prognosis in Patients with Diabetic Nephropathy, Kidney International, 62, 220228 (2002)
  11. Thomas I., Justesen Et Al, Albumin-To-Creatinine Ratio In Random Urine Samples Might Replace 24-H Urine Collections In Screening For Micro- And Macroalbuminuria In Pregnant Woman With Type 1 Diabetes, Diabetes Care, 29(4), (2006)
  12. Philip Mcfarlane, Chronic Kidney Disease in Diabetes, Can J Diabetes, 37, S129-136 (2013)